Program 13 Gynecological disorders(253 cases)
Gyne-1-vulva_Gyne-vulva (1-21)_Au_54F_HE_normal clitoris
Gyne-2-vulva_Gyne-vulva (1-21)_Ex_52F_HE_Bartholin's gland cyst
Gyne-3-1-vulva_Gyne-vulva (1-21)_Ex_60F_HE_Skene's gland cyst
Gyne-3-2-vulva_Gyne-vulva (1-21)_Au_adultsF_HE/PAS/IHC_normal female paraurethral gland (Skene’s gland)
Gyne-4-vulva_Gyne-vulva (1-21)_Bx_20F_HE_lymphogranuloma venereum (4th venereal disease/Chlamydia trachomatis infection)
Gyne-5-1-vulva_Gyne-vulva (1-21)_Bx_22F_HE_candidal vulvitis-1
Gyne-5-2-vulva_Gyne-vulva (1-21)_Bx_22F_Gram_candidal vulvitis-2
Gyne-6-1-vulva_Gyne-vulva (1-21)_Bx_81F_HE_vulvar herpes-1
Gyne-6-2-vulva_Gyne-vulva (1-21)_Bx_81F_IHC (HSV)_vulvar herpes-2
Gyne-7-vulva_Gyne-vulva (1-21)_Bx_39F_HE_molluscum contagiosum
Gyne-8-vulva_Gyne-vulva (1-21)_Ex_20F_HE_condyloma acuminatum
Gyne-9-1-vulva_Gyne-vulva (1-21)_Ex_48F_HE_giant condyloma acuminatum-1
Gyne-9-2-vulva_Gyne-vulva (1-21)_Ex_48F_ISH (HPV)_giant condyloma acuminatum-2
Gyne-10-1-vulva_Gyne-vulva (1-21)_Ex_48F_HE_condylomatous carcinoma, exceptionally producing HPV virions-1
Gyne-10-2-vulva_Gyne-vulva (1-21)_Ex_48F_IHC (HPV)_condylomatous carcinoma, exceptionally producing HPV virions-2
Gyne-10-3-vulva_Gyne-vulva (1-21)_Ex_48F_ISH (HPV)_condylomatous carcinoma, exceptionally producing HPV virions-3
Gyne-10-4-vulva_Gyne-vulva (1-21)_Ex_48F_IHC (Ki-67)_condylomatous carcinoma, exceptionally producing HPV virions-4
Gyne-11-1-vulva_Gyne-vulva (1-21)_Bx_35F_HE_vulvar intraepithelial neoplasia (VIN)-1
Gyne-11-2-vulva_Gyne-vulva (1-21)_Bx_35F_ISH (HPV)_vulvar intraepithelial neoplasia (VIN)-2
Gyne-12-vulva_Gyne-vulva (1-21)_Bx_43F_HE_bowenoid papulosis
Gyne-13-vulva_Gyne-vulva (1-21)_Parasite_4F_HE_Enterobius vermicularis (pinworm), femalle adult
Gyne-14-vulva_Gyne-vulva (1-21)_Bx_64F_HE_extramammary Paget's disease
Gyne-15-vulva_Gyne-vulva (1-21)_Ex_35F_HE_fibroadenoma
Gyne-16-vulva_Gyne-vulva (1-21)_Ex_29F_HE_hidradenoma papilliferum
Gyne-17-vulva_Gyne-vulva (1-21)_Ex_31F_HE_apocrine adenoma
Gyne-18-vulva_Gyne-vulva (1-21)_Ex_60F_HE_granular cell tumor
Gyne-19-vulva_Gyne-vulva (1-21)_Ex_42F_HE_aggressive angiomyxoma
Gyne-20-vulva_Gyne-vulva (1-21)_Rx_51F_HE_low-grade fibromyxoid sarcoma
Gyne-21-vulva_Gyne-vulva (1-21)_Rx_19F_HE_rhabdomyosarcoma, embryonal type
Gyne-22-1-vagina_Gyne-vagina (22-41)_Au_50'sF_HE_normal Merkel cells in the vaginal squamous mucosa-1
Gyne-22-2-vagina_Gyne-vagina (22-41)_Au_50'sF_IHC (CK20)_normal Merkel cells in the vaginal squamous mucosa-2
Gyne-22-a-vagina_Gyne-vagina (22-41)_Au/Bx_adultsF_HE/IHC/EM_mystery of the G-spot on the anterior wall of the vagina
Gyne-23-1-vagina_Gyne-vagina (22-41)_Ex_72F_HE_intravaginal foreign body (banana)
Gyne-23-2-vagina_Gyne-vagina (22-41)_Ex_72F_Grocott_intravaginal foreign body (banana)
Gyne-24-vagina_Gyne-vagina (22-41)_Ex_54F_HE_Gartner's duct cyst (wolffian cyst)
Gyne-25-1-vagina_Gyne-vagina (22-41)_Ex_22F_HE_mucinous cyst of müllerian origin
Gyne-25-2-vagina_Gyne-vagina (22-41)_Ex_48F_HE_ciliated epithelial inclusion cyst of müllerian origin
Gyne-26-vagina_Gyne-vagina (22-41)_Ex_33F_HE_vaginal inclusion cyst
Gyne-27-vagina_Gyne-vagina (22-41)_Bx_65F_HE_Fordyce spots
Gyne-28-1-vagina_Gyne-vagina (22-41)_Bx_26F_HE_vaginal squams with Döderlein bacilli colonization-1
Gyne-28-2-vagina_Gyne-vagina (22-41)_Bx_26F_Gram_vaginal squams with Döderlein bacilli colonization-2
Gyne-29-vagina_Gyne-vagina (22-41)_Ex_73F_HE_vesico-vaginal fistula
Gyne-30-vagina_Gyne-vagina (22-41)_Ex_41F_HE_hematoma
Gyne-31-vagina_Gyne-vagina (22-41)_Ex_80F_HE_polypoid granulation tissue
Gyne-32-vagina_Gyne-vagina (22-41)_Bx_50F_HE_fibrotic nodule
Gyne-33-vagina_Gyne-vagina (22-41)_Px_40F_HE_soft fibroma (fibroepithelial stromal polyp)
Gyne-34-vagina_Gyne-vagina (22-41)_Ex_80F_HE_pseudocarcinomatous hyperplasia
Gyne-35-vagina_Gyne-vagina (22-41)_Ex_63F_HE_angiomyofibroblastoma
Gyne-36-1-vagina_Gyne-vagina (22-41)_Ex_38F_HE_placental site trophoblastic tumor, vaginal metastasis
Gyne-36-2-vagina_Gyne-vagina (22-41)_Ex_38F_HE/IHC/macro_placental site trophoblastic tumor (PSTT)
Gyne-37-vagina_Gyne-vagina (22-41)_Bx_75F_HE_papillary squamous cell carcinoma
Gyne-38-1-vagina_Gyne-vagina (22-41)_Ex_51F_HE_mucinous carcinoma of the vagina
Gyne-38-2-vagina_Gyne-vagina (22-41)_Rx_65F_HE_poorly differentiated adenocarcinoma of vagina
Gyne-39-vagina_Gyne-vagina (22-41)_Ex_1yr2moF_HE_botryoid sarcoma
Gyne-39-a-vagina_Gyne-vagina (22-41)_Rx_60'sF_HE/silver/IHC_leiomyosarcoma of the vagina
Gyne-40-vagina_Gyne-vagina (22-41)_Rx_31F_HE_recurrent amelanotic melanoma
Gyne-41-vagina_Gyne-vagina (22-41)_Ex_29F_HE_metastatic islet cell tumor
Gyne-42-cervix_Gyne-cervix (42-102)_Bx_48F_HE_melanocytic melanosis
Gyne-43-cervix_Gyne-cervix (42-102)_Rx_42F_HE_Gartner's duct (wolffian duct)
Gyne-44-cervix_Gyne-cervix (42-102)_Rx_32F_HE_Gartner's duct hyperplasia (hamartoma)
Gyne-45-cervix_Gyne-cervix (42-102)_Rx_44F_HE_diverticulum of uterine cervix
Gyne-46-1-cervix_Gyne-cervix (42-102)_Rx_51F_HE_isolated necrotizing angiitis-1
Gyne-46-2-cervix_Gyne-cervix (42-102)_Rx_36F_HE_isolated necrotizing angiitis-2
Gyne-47-cervix_Gyne-cervix (42-102)_Ex_49F_HE_Nabothian follicles, polypoid
Gyne-48-cervix_Gyne-cervix (42-102)_Bx_49F_HE_chronic cervicitis with cervical gland hyperplasia
Gyne-49-cervix_Gyne-cervix (42-102)_Bx_58F_HE_chronic cervicitis with globe powder deposition
Gyne-50-1-cervix_Gyne-cervix (42-102)_Bx_44F_HE_squamous metaplasia (reserve cell hyperplasia)
Gyne-50-2-cervix_Gyne-cervix (42-102)_Bx_30'sF_HE_reserve cell hyperplasia
Gyne-51-cervix_Gyne-cervix (42-102)_Bx_49F_HE_acanthosis of skin type
Gyne-52-cervix_Gyne-cervix (42-102)_Px_32F_HE_squamous metaplasia with polypoid formation
Gyne-53-1-cervix_Gyne-cervix (42-102)_Bx_49F_HE_senile colpitis
Gyne-53-2-cervix_Gyne-cervix (42-102)_Bx/cytology_agedF_HE/Pap/IHC_ senile colpitis or dysplasia?the usefulness of p16 immunostaining in post-menopausal cytology
Gyne-54-cervix_Gyne-cervix (42-102)_Bx_72F_HE_true erosion with reactive acanthosis
Gyne-55-cervix_Gyne-cervix (42-102)_Bx_28F_HE_follicular cervicitis
Gyne-56-1-cervix_Gyne-cervix (42-102)_Bx_27F_HE_decidual stroma of the uterine cervix
Gyne-56-2-cervix_Gyne-cervix (42-102)_Bx_26F_HE_extravillous (intermediate) trophoblasts in the uterine cervix
Gyne-57-cervix_Gyne-cervix (42-102)_Ex_45F_HE_prolapsed uterine leiomyoma
Gyne-58-1-cervix_Gyne-cervix (42-102)_Px_30'sF_HE_secondary streptococcal infection on a twisted cervical polyp-1
Gyne-58-2-cervix_Gyne-cervix (42-102)_Px_30'sF_IHC (Strepto)_secondary streptococcal infection on a twisted cervical polyp-2
Gyne-59-cervix_Gyne-cervix (42-102)_Px_adult F_HE-IHC (G. vaginalis)_Ischemic cervical polyp with Gardnerella vaginalis infection
Gyne-60-1-cervix_Gyne-cervix (42-102)_Px_37F_HE_erosive cervical polyp with Döderlein bacilli colonization-1
Gyne-60-2-cervix_Gyne-cervix (42-102)_Px_37F_Gram_erosive cervical polyp with Döderlein bacilli colonization-2
Gyne-61-cervix_Gyne-cervix (42-102)_Bx_55F_HE_tuberculosis of the uterine cervix
Gyne-62-1-cervix_Gyne-cervix (42-102)_Bx_20F_HE_chlamydial cervicitis-1
Gyne-62-2-cervix_Gyne-cervix (42-102)_Bx_20F_IHC (C. trachomatis)_chlamydial cervicitis-2
Gyne-62-3-cervix_Gyne-cervix (42-102)_Bx/cytology_adults_HE/pap/IHC/macro_sexy pathology: Japanese sex life realized from pathology specimens
Gyne-62-4-cervix_Gyne-cervix (42-102)_Bx_adults_HE/IHC/EM/macro_pathology of sexually transmitted infections
Gyne-63-1-cervix_Gyne-cervix (42-102)_Bx_30F_HE_uterine cervical candidosis on mild dysplasia-1
Gyne-63-2-cervix_Gyne-cervix (42-102)_Bx_30F_Grocott_uterine cervical candidosis on mild dysplasia-2
Gyne-63-3-cervix_Gyne-cervix (42-102)_Bx_30F_IHC (Candida)_uterine cervical candidosis on mild dysplasia-3
Gyne-64-cervix_Gyne-cervix (42-102)_Bx_35F_HE_HSV infection of the uterine cervix
Gyne-65-cervix_Gyne-cervix (42-102)_Rx_32F_HE_bilharziasis accompanying uterine cervical ulcer
Gyne-66-cervix_Gyne-cervix (42-102)_Bx_-_HE/Pap_Collections of pollens
Gyne-67-cervix_Gyne-cervix (42-102)_Px_80F_HE_polypoid granulation tissue
Gyne-68-1-cervix_Gyne-cervix (42-102)_Px_37F_HE_endocervical polyp (two-headed)
Gyne-68-2-cervix_Gyne-cervix (42-102)_Px_38F_HE_endocervical polyp with microglandular hyperplasia
Gyne-68-3-cervix_Gyne-cervix (42-102)_Px_34F_HE_endocervical polyp with microglandular hyperplasia with intracytoplasmic lumina
Gyne-68-4-cervix_Gyne-cervix (42-102)_Px_67F_HE_cervical polyp with extensive squamous metaplasia
Gyne-68-5-cervix_Gyne-cervix (42-102)_Px_47F_HE_endocervical polyp with lymphoid stroma
Gyne-68-6-cervix_Gyne-cervix (42-102)_Px_31F_HE_endocervical polyp with foamy cell accumulation
Gyne-68-7-cervix_Gyne-cervix (42-102)_Px_30F_HE_endocervical polyp with decidual reaction
Gyne-68-8-cervix_Gyne-cervix (42-102)_Px_35F_HE_endocervical polyp with streptococcal infection
Gyne-68-9-1-cervix_Gyne-cervix (42-102)_Px_23F_HE_endocervical polyp with chlamydial infection-1
Gyne-68-9-2-cervix_Gyne-cervix (42-102)_Px_23F_IHC (CT-Ag)_endocervical polyp with chlamydial infection-2
Gyne-68-10-cervix_Gyne-cervix (42-102)_Px_45F_HE_endocervical polyp with severe dysplasia
Gyne-68-11-cervix_Gyne-cervix (42-102)_Px_48F_HE_endocervical polyp with glandular dysplasia
Gyne-68-12-cervix_Gyne-cervix (42-102)_Px_48F_HE_endocervical polyp with cervical adenocarcinoma
Gyne-69-cervix_Gyne-cervix (42-102)_Px_20F_HE_hamartomatous endocervical polyp
Gyne-70-1-cervix_Gyne-cervix (42-102)_Px_42F_HE_endometrial polyp
Gyne-70-2-cervix_Gyne-cervix (42-102)_Px_34F_HE_endometrial polyp in pregnancy
Gyne-71-1-cervix_Gyne-cervix (42-102)_Px_38F_HE_atypical endometrial hyperplasia as endocervical polyp
Gyne-71-2-cervix_Gyne-cervix (42-102)_Px_80F_HE_endometrioid carcinoma in endometrial polyp
Gyne-72-cervix_Gyne-cervix (42-102)_Px_53F_HE_adenomyoma of endocervical type, polypoid type
Gyne-73-cervix_Gyne-cervix (42-102)_Rx_56F_HE_angiomyolipoma
Gyne-74-1-cervix_Gyne-cervix (42-102)_Bx_53F_HE_regenerative squamous mucosa
Gyne-74-2-cervix_Gyne-cervix (42-102)_Bx_32F_HE_atypical metaplasia
Gyne-75-1-cervix_Gyne-cervix (42-102)_Bx_45F_HE_condyloma acuminatum
Gyne-75-2-cervix_Gyne-cervix (42-102)_conization_34F_HE_condylomatosis of the uterine cervix
Gyne-76-1-cervix_Gyne-cervix (42-102)_Bx_23F_HE_mild dysplasia with koilocytic atypia-1
Gyne-76-2-cervix_Gyne-cervix (42-102)_Bx_23F_IHC (HPV)_mild dysplasia with koilocytic atypia-2
Gyne-76-3-cervix_Gyne-cervix (42-102)_Bx_23F_ISH (HPV)_mild dysplasia with koilocytic atypia-3
Gyne-76-a-cervix_Gyne-cervix (42-102)_Bx_35F_HE_mild dysplasia with pseudoinvasive growth
Gyne-77-1-cervix_Gyne-cervix (42-102)_Bx_37F_HE_moderate dysplasia
Gyne-77-2-cervix_Gyne-cervix (42-102)_Bx_30F_HE_moderate/severe dysplasia with glandular involvement
Gyne-78-1-cervix_Gyne-cervix (42-102)_Bx_39F_HE_severe dysplasia focally with koilocytosis-1
Gyne-78-2-cervix_Gyne-cervix (42-102)_Bx_39F_ISH (HPV)_severe dysplasia focally with koilocytosis-2
Gyne-78-3-cervix_Gyne-cervix (42-102)_Bx_39F_IHC (HPV16)_severe dysplasia focally with koilocytosis-3
Gyne-79-1-cervix_Gyne-cervix (42-102)_Bx_86F_HE_carcinoma in situ, papillary type-1
Gyne-79-2-cervix_Gyne-cervix (42-102)_Bx_86F_ISH (HPV)_carcinoma in situ, papillary type-2
Gyne-79-3-cervix_Gyne-cervix (42-102)_Bx_86F_IHC (p16)_carcinoma in situ, papillary type-3
Gyne-80-1-cervix_Gyne-cervix (42-102)_Bx_29F_HE_carcinoma in situ with ectopic chromosome around centrosome
Gyne-80-2-cervix_Gyne-cervix (42-102)_Bx_20's/40'sF_HE_ectopic chromosome around centrosome in metaphase cell nuclei of high-risk HPV-related cervical neoplasia
Gyne-80-3-cervix_Gyne-cervix (42-102)_Bx_31F_HE_carcinoma in situ with glandular involvement
Gyne-80-4-cervix_Gyne-cervix (42-102)_conization_27F_HE_carcinoma in situ with downward growth
Gyne-80-5-cervix_Gyne-cervix (42-102)_Bx_30F_HE_carcinoma in situ with ciliated cell lining
Gyne-80-6-cervix_Gyne-cervix (42-102)_Bx_75F_HE_carcinoma in situ, differentiated type
Gyne-80-7-cervix_Gyne-cervix (42-102)_conization_45F_HE_carcinoma in situ, verrucous type
Gyne-81-1-cervix_Gyne-cervix (42-102)_Bx_47F_HE_invasive squamous cell carcinoma-1
Gyne-81-2-cervix_Gyne-cervix (42-102)_Bx_47F_ISH (HPV)_invasive squamous cell carcinoma-2
Gyne-82-1-cervix_Gyne-cervix (42-102)_conization_29F_HE_squamous cell carcinoma, early invasive-1
Gyne-82-2-cervix_Gyne-cervix (42-102)_Bx_62F_HE_squamous cell carcinoma, early invasive-2
Gyne-82-3-cervix_Gyne-cervix (42-102)_Bx_82F_HE_squamous cell carcinoma, invasive, keratinizing
Gyne-82-4-cervix_Gyne-cervix (42-102)_Ex_68F_HE_squamous cell carcinoma, large cell non-keratinizing
Gyne-82-5-cervix_Gyne-cervix (42-102)_Rx_60F_HE_squamous cell carcinoma, small cell non-keratinizing type
Gyne-82-6-cervix_Gyne-cervix (42-102)_Rx_53F_HE_squamous cell carcinoma, acantholytic type
Gyne-82-7-cervix_Gyne-cervix (42-102)_Rx_80F_HE_squamous cell carcinoma, basaloid, invasive
Gyne-83-cervix_Gyne-cervix (42-102)_Rx_41F_HE_glassy cell carcinoma
Gyne-84-cervix_Gyne-cervix (42-102)_Bx_57F_HE_papillary hyperplasia of cervical glands
Gyne-85-1-cervix_Gyne-cervix (42-102)_Bx_31F_HE_glandular dysplasia-1
Gyne-85-2-cervix_Gyne-cervix (42-102)_Bx_31F_ISH (HPV)_glandular dysplasia-2
Gyne-86-cervix_Gyne-cervix (42-102)_Rx_36F_HE_papillary adenocarcinoma in situ
Gyne-87-cervix_Gyne-cervix (42-102)_Rx_47F_HE_lobular endocervical glandular hyperplasia
Gyne-88-1-cervix_Gyne-cervix (42-102)_Rx_40'sF_HE_adenoma malignum
Gyne-88-2-cervix_Gyne-cervix (42-102)_Rx_48F_HE/IHC/PCS_adenoma malignum (minimal deviation adenocarcinoma)
Gyne-89-1-cervix_Gyne-cervix (42-102)_Rx_48F_HE_gastric-type cervical adenocarcinoma-1
Gyne-89-2-cervix_Gyne-cervix (42-102)_Bx_41F_HE_gastric-type cervical adenocarcinoma-2, papillary
Gyne-90-cervix_Gyne-cervix (42-102)_Rx_66F_HE_adenocarcinoma, poorly differentiated
Gyne-91-1-cervix_Gyne-cervix (42-102)_Bx_42F_HE_mucoepidermoid carcinoma
Gyne-91-2-cervix_Gyne-cervix (42-102)_Bx_72F_HE_adenoid cystic carcinoma, high-grade
Gyne-92-cervix_Gyne-cervix (42-102)_Rx_61F_HE_adenosquamous carcinoma
Gyne-93-cervix_Gyne-cervix (42-102)_Bx_67F_HE_clear cell carcinoma
Gyne-94-cervix_Gyne-cervix (42-102)_Rx_30F_HE_lymphoepithelioma-like carcinoma
Gyne-95-cervix_Gyne-cervix (42-102)_Rx_50F_HE_carcinoid tumor of cervix (NET, G2)
Gyne-96-cervix_Gyne-cervix (42-102)_Ex_60'sF_HE_adenocarcinoma admixed with neuroendocrine carcinoma
Gyne-97-1-1-cervix_Gyne-cervix (42-102)_Rx_34F_HE_small cell neuroendocrine carcinoma
Gyne-97-1-2-cervix_Gyne-cervix (42-102)_Rx_40F_HE/Grimelius/IHC_small cell neuroendocrine carcinoma of the uterine cervix
Gyne-97-2-cervix_Gyne-cervix (42-102)_Bx_82F_HE_large cell neuroendocrine carcinoma
Gyne-98-cervix_Gyne-cervix (42-102)_Rx_31F_HE_anaplastic carcinoma (giant cell carcinoma)
Gyne-99-1-cervix_Gyne-cervix (42-102)_Ex_51F_HE_carcinosarcoma-1
Gyne-99-2-cervix_Gyne-cervix (42-102)_Ex_51F_IHC (CD10)_carcinosarcoma-2
Gyne-100-cervix_Gyne-cervix (42-102)_Bx_52F_HE_malignant Müllerian mixed tumor with rhabdomyosarcomatous component
Gyne-101-cervix_Gyne-cervix (42-102)_Bx_59F_HE_leiomyosarcoma
Gyne-102-cervix_Gyne-cervix (42-102)_Rx_43F_HE_extramedullary plasmacytoma
Gyne-103-1-EM_Gyne-EM (103-142)_D&C_61F_HE_pyometra with inactive endometrium
Gyne-103-2-EM_Gyne-EM (103-142)_Rx_89F_HE_ruptured pyometra
Gyne-104-EM_Gyne-EM (103-142)_Au_38F_HE/IHC/macro_Streptococcal endometritis in the puerperal uterus provoking fulminant streptococcal infection (puerperal fever)
Gyne-105-EM_Gyne-EM (103-142)_D&C_61F_HE_actinomycosis
Gyne-106-1-EM_Gyne-EM (103-142)_Bx_32F_HE_sperm clusters on endometrium
Gyne-106-2-EM_Gyne-EM (103-142)_Bx_27F_HE_xanthogranuloma with sperms in Douglas' pouch
Gyne-107-EM_Gyne-EM (103-142)_Bx_63F_HE_planktons in the endometrium (artificial contamination)
Gyne-108-1-1-EM_Gyne-EM (103-142)_Px_36F_HE_endometrial polyp-1
Gyne-108-1-2-EM_Gyne-EM (103-142)_Px_36F_IHC (CD56)_endometrial polyp-2
Gyne-108-2-EM_Gyne-EM (103-142)_Px_31F_HE_endometrial polyp with early secretory appearance
Gyne-108-3-EM_Gyne-EM (103-142)_Px_47F_HE_endometrial polyp with decidual stromal change
Gyne-109-1-EM_Gyne-EM (103-142)_Bx_47F_HE_early proliferative phase
Gyne-109-2-EM_Gyne-EM (103-142)_Bx_40'sF_HE_late proliferative phase
Gyne-110-EM_Gyne-EM (103-142)_Bx_32F_HE_early secretory endometrium
Gyne-111-EM_Gyne-EM (103-142)_Bx_32F_HE_late secretory endometrium
Gyne-111-a-EM_Gyne-EM (103-142)_Bx_adults_HE/enzyme histochemistry_enzyme histochemistry of the endometrium
Gyne-112-EM_Gyne-EM (103-142)_Bx_78F_HE_atrophic endometrium with cystic change
Gyne-113-EM_Gyne-EM (103-142)_D&C_43F_HE_mixed endometrium
Gyne-114-1-EM_Gyne-EM (103-142)_Bx_36F_HE_stromoglandular disparity
Gyne-114-2-EM_Gyne-EM (103-142)_D&C_43F_HE_desquamating endometrium with stromoglandular disparity
Gyne-115-1-1-EM_Gyne-EM (103-142)_Bx_48F_HE_tubal (ciliated) metaplasia
Gyne-115-1-2-EM_Gyne-EM (103-142)_Bx_48F_IHC (tubulin)_tubal (ciliated) metaplasia
Gyne-115-2-EM_Gyne-EM (103-142)_Bx_48F_HE_hobnail metaplasia
Gyne-115-3-EM_Gyne-EM (103-142)_Bx_44F_HE_morule formation in early secretory phase
Gyne-116-1-EM_Gyne-EM (103-142)_Bx_35F_HE_inactive endometrium with desmin-positive stromal cells-1
Gyne-116-2-EM_Gyne-EM (103-142)_Bx_35F_IHC (desmin)_inactive endometrium with desmin-positive stromal cells-2
Gyne-116-3-EM_Gyne-EM (103-142)_Bx_38F_HE_inactive endometrium with pseudopapillary stromoglandular structures
Gyne-117-EM_Gyne-EM (103-142)_Bx_56F_HE_menstruation
Gyne-118-EM_Gyne-EM (103-142)_D&C_45F_HE_chronic endometritis
Gyne-119-1-EM_Gyne-EM (103-142)_D&C_45F_HE_desquamating endometrium with inactive glands
Gyne-119-2-EM_Gyne-EM (103-142)_Bx_47F_HE_desquamating endometrium in proliferative phase
Gyne-119-3-EM_Gyne-EM (103-142)_D&C_42F_HE_desquamating endometrium with secretory features
Gyne-119-4-EM_Gyne-EM (103-142)_Bx_49F_HE_desquamating endometrium, resembling endometrioid carcinoma
Gyne-119-5-EM_Gyne-EM (103-142)_Bx_-_HE_pathology of the endometrium in functional bleeding
Gyne-120-EM_Gyne-EM (103-142)_Bx_31F_HE_endometrial stromal hyperplasia
Gyne-121-1-EM_Gyne-EM (103-142)_D&C_44F_HE_cystic glandular hyperplasia
Gyne-121-2-EM_Gyne-EM (103-142)_D&C_41F_HE_cystic glandular hyperplasia with desquamative change
Gyne-122-1-EM_Gyne-EM (103-142)_D&C_51F_HE_Lehman-Hart proliferation (papillary proliferation of endometrium) with squamous metaplasia
Gyne-122-2-EM_Gyne-EM (103-142)_D&C_61F_HE_Lehman-Hart proliferation (papillary proliferation of endometrium) with desquamative change
Gyne-123-EM_Gyne-EM (103-142)_Bx_62F_HE_papillary mucinous metaplasia
Gyne-124-EM_Gyne-EM (103-142)_D&C_35F_HE_atypical polypoid adenomyoma
Gyne-125-1-1-EM_Gyne-EM (103-142)_Bx_34F_HE_adenomatous hyperplasia
Gyne-125-1-2-EM_Gyne-EM (103-142)_Bx_57F_HE/IHC_hormone receptor expression in atypical endometrial hyperplasia
Gyne-125-2-EM_Gyne-EM (103-142)_Bx_46F_HE_adenomatous hyperplasia with papillary growth
Gyne-125-3-EM_Gyne-EM (103-142)_Bx_27F_HE_adenomatous hyperplasia with morule formation
Gyne-126-1-EM_Gyne-EM (103-142)_Bx_47F_HE_atypical endometrial hyperplasia
Gyne-126-2-EM_Gyne-EM (103-142)_D&C_41F_HE_atypical endometrial hyperplasia/endometrioid carcinoma in situ (EIN)
Gyne-126-3-EM_Gyne-EM (103-142)_Bx_37F_HE_atypical endometrial hyperplasia, papillary type
Gyne-126-4-EM_Gyne-EM (103-142)_Ex_47F_HE_endometrioid carcinoma (G1) in atypical endometrial hyperplasia
Gyne-127-EM_Gyne-EM (103-142)_Bx_69F_HE_mixed endometrioid and mucinous carcinoma
Gyne-128-1-1-EM_Gyne-EM (103-142)_Rx_56F_HE (Em)_endometrioid carcinoma (G1), invasive
Gyne-128-1-2-EM_Gyne-EM (103-142)_Rx_56F_HE (ovary)_endometrioid carcinoma (G1) of the ovary
Gyne-128-2-1-EM_Gyne-EM (103-142)_Rx_52F_HE (EM)_endometrioid carcinoma (G1) with benign ectopic glands in the lymph node-1
Gyne-128-2-2-EM_Gyne-EM (103-142)_Rx_52F_HE (LN)_endometrioid carcinoma (G1) with benign ectopic glands in the lymph node-2
Gyne-128-3-EM_Gyne-EM (103-142)_D&C_51F_HE_endometrioid carcinoma with villoglandular variant
Gyne-128-4-EM_Gyne-EM (103-142)_Bx_70F_HE_endometrioid carcinoma with secretory variant
Gyne-128-5-EM_Gyne-EM (103-142)_Rx_50F_HE_endometrioid carcinoma, poorly differentiated (G3)
Gyne-129-EM_Gyne-EM (103-142)_Rx_75F_HE_endometrioid carcinoma arising from adenomyosis
Gyne-129-a-EM_Gyne-EM (103-142)_Rx_56F/70F_HE/IHC/macro_endometrioid carcinoma: immunohistochemical markers
Gyne-130-1-EM_Gyne-EM (103-142)_D&C_33F_HE_endometrioid carcinoma followed by ectopic pregnancy-1
Gyne-130-2-EM_Gyne-EM (103-142)_D&C_34F_HE_endometrioid carcinoma followed by ectopic pregnancy-2
Gyne-130-3-EM_Gyne-EM (103-142)_D&C_35F_HE_endometrioid carcinoma followed by ectopic pregnancy-3
Gyne-131-1-EM_Gyne-EM (103-142)_Bx_75F_HE_endometrioid carcinoma with squamous differentiation (adenoacanthoma)
Gyne-131-2-EM_Gyne-EM (103-142)_Bx_68F_HE_adenosquamous carcinoma
Gyne-131-3-EM_Gyne-EM (103-142)_Bx_64F_HE_microglandular adenocarcinoma of the endometrium
Gyne-131-4-EM_Gyne-EM (103-142)_Rx/Au_45F/30'sF_HE/IHC/macro_G-CSF-producing endometrial carcinoma
Gyne-132-EM_Gyne-EM (103-142)_Rx_69F_HE_serous carcinoma of the endometrium
Gyne-133-1-EM_Gyne-EM (103-142)_D&C_64F_HE_clear cell carcinoma-1
Gyne-133-2-EM_Gyne-EM (103-142)_Rx_82F_HE_clear cell carcinoma-2
Gyne-134-EM_Gyne-EM (103-142)_Rx_46F_HE_endometrioid carcinoma with large cell neuroendoicrine component
Gyne-135-EM_Gyne-EM (103-142)_Rx_67F_HE_AFP-producing carcinoma of the endometrium
Gyne-136-1-EM_Gyne-EM (103-142)_Rx_54F_HE_anaplastic carcinoma with papillary endometrioid carcinoma (G3)
Gyne-136-2-EM_Gyne-EM (103-142)_Rx_62F_HE/IHC/macro_anaplastic carcinoma (dedifferentiated carcinoma) of the endometrium
Gyne-137-EM_Gyne-EM (103-142)_Rx_44F_HE_Müllerian adenosarcoma
Gyne-138-1-EM_Gyne-EM (103-142)_Rx_58F_HE_carcinosarcoma (endometrioid carcinoma with sarcomatous transformation)
Gyne-138-2-EM_Gyne-EM (103-142)_Rx_70F_HE_malignant mixed Müllerian tumor with rhabdomyosarcomatous component
Gyne-138-3-EM_Gyne-EM (103-142)_Bx_60'sF_HE_malignant mixed Müllerian tumor with osteosarcomatous component
Gyne-139-EM_Gyne-EM (103-142)_D&C_15F_HE_malignant mesenchymoma with metaplastic squamous cells
Gyne-140-1-EM_Gyne-EM (103-142)_Rx_50F_HE_endometrial stromal sarcoma, low-grade
Gyne-140-2-EM_Gyne-EM (103-142)_Rx_33F_HE_endolymphatic stromal myosis
Gyne-140-3-EM_Gyne-EM (103-142)_Rx_47F_HE_endolymphatic stromal myosis, recurrent, with endometrial glands
Gyne-140-4-EM_Gyne-EM (103-142)_Rx_71F_HE_endometrial stromal sarcoma, high-grade
Gyne-141-EM_Gyne-EM (103-142)_Rx_55F_HE_mixed endometrial stromal and smooth muscle tumor
Gyne-142-EM_Gyne-EM (103-142)_Bx_51F_HE_malignant lymphoma
Gyne-142-a-EM_Gyne-EM (103-142)_Rx_61F_HE/IHC/EM_malignant melanoma of the endometrium
Gyne-143-1-Preg_Gyne-Preg (143-152)_D&C_33F_HE_spontaneous abortion
Gyne-143-2-Preg_Gyne-Preg (143-152)_D&C_35F_HE_abortion with nucleated red cells
Gyne-143-3-Preg_Gyne-Preg (143-152)_D&C_37F_HE_abortion with bizarre intermediate trophoblasts
Gyne-143-4-Preg_Gyne-Preg (143-152)_D&C_35F_HE_abortion with syncytiotrophoblastic giant cells in the stroma
Gyne-143-5-Preg_Gyne-Preg (143-152)_D&C_40F_HE_abortion with active trophoblastic growth
Gyne-143-6-Preg_Gyne-Preg (143-152)_D&C_31F_HE_abortion with prominent Arias-Stella reaction
Gyne-143-7-Preg_Gyne-Preg (143-152)_D&C_36F_HE_abortion with myxoid change of stromal cells
Gyne-143-8-Preg_Gyne-Preg (143-152)_D&C_35F_HE_abortion with amniotic membrane
Gyne-143-9-Preg_Gyne-Preg (143-152)_D&C_36F_HE_abortion, calcified fetus+
Gyne-143-10-Preg_Gyne-Preg (143-152)_D&C_35F_HE_abortion with an empty sac containing yolk sac tissue
Gyne-143-11-Preg_Gyne-Preg (143-152)_D&C_32F_HE_abortion with fetal and yolk sac components
Gyne-143-12-Preg_Gyne-Preg (143-152)_D&C_27F_HE_fetus (brain/eye ball/kidney/hand)
Gyne-143-13-Preg_Gyne-Preg (143-152)_D&C_40F_HE_fetus, 11 mm in length
Gyne-143-14-Preg_Gyne-Preg (143-152)_D&C_fetus_HE/IHC/macro_normal yolk sac
Gyne-143-15-Preg_Gyne-Preg (143-152)_Rx_adults_macro_gross appearance of pregnant uterus
Gyne-144-1-Preg_Gyne-Preg (143-152)_D&C_27F_HE_complete abortion
Gyne-144-2-Preg_Gyne-Preg (143-152)_D&C_34F_HE_abortion, implantation site
Gyne-145-Preg_Gyne-Preg (143-152)_D&C_46F_HE_abortion with coccal infection
Gyne-146-Preg_Gyne-Preg (143-152)_D&C_32F_HE_ectopic pregnancy
Gyne-147-1-Preg_Gyne-Preg (143-152)_D&C_41F_HE_decidual rest
Gyne-147-2-Preg_Gyne-Preg (143-152)_D&C_32F_HE_placental rest
Gyne-148-Preg_Gyne-Preg (143-152)_Rx_31F_HE_puerperal uterus
Gyne-149-1-Preg_Gyne-Preg (143-152)_Rx_31F_HE_amniotic fluid emboilism-1
Gyne-149-2-Preg_Gyne-Preg (143-152)_Rx_31F_HE/macro_amniotic fluid emboilism-2
Gyne-150-1-Preg_Gyne-Preg (143-152)_D&C_43F_HE_abortion, hydropic change+
Gyne-150-2-Preg_Gyne-Preg (143-152)_D&C_31F_HE_pseudomole
Gyne-150-3-Preg_Gyne-Preg (143-152)_Ex_38F_HE_partial hydatidiform mole
Gyne-150-4-Preg_Gyne-Preg (143-152)_D&C_44F_HE_complete hydatidiform mole
Gyne-150-5-Preg_Gyne-Preg (143-152)_D&C_34F_HE_hydatidiform mole with active trophoblastic growth
Gyne-150-6-Preg_Gyne-Preg (143-152)_D&C_adults_HE/IHC_usefulness of p57-kip2 immunostaining in differentiating between complete and partial hydatidiform mole
Gyne-151-1-Preg_Gyne-Preg (143-152)_Rx_29F_HE_invasive mole-1
Gyne-151-2-Preg_Gyne-Preg (143-152)_Rx_29F_HE/macro_invasive mole-2
Gyne-152-Preg_Gyne-Preg (143-152)_Rx_27F_HE_choriocarcinoma
Gyne-153-uterus_Gyne-uterus (153-162)_Rx_37F_HE_myometrial necrosis caused by GPC infection. S/P: caesarian section
Gyne-154-uterus_Gyne-uterus (153-162)_Au_40'sF_HE_uterine infarction
Gyne-155-1-uterus_Gyne-uterus (153-162)_Rx_78F_HE_uterine prolapse-1, senile endometrial atrophy
Gyne-155-2-uterus_Gyne-uterus (153-162)_Rx_78F_HE_uterine prolapse-2, true cervical erosion
Gyne-156-1-uterus_Gyne-uterus (153-162)_Rx_39F_HE_adenomyosis
Gyne-156-2-uterus_Gyne-uterus (153-162)_Rx_47F_HE_adenomyosis with lymphatic invasion
Gyne-156-3-uterus_Gyne-uterus (153-162)_Rx_49F_HE_adenomyosis in leiomyoma
Gyne-156-4-uterus_Gyne-uterus (153-162)_Rx_49F_HE_adenomyosis with papillary hyperplasia
Gyne-156-5-uterus_Gyne-uterus (153-162)_Rx_35F_HE_myometriosis (stromal adenomyosis)
Gyne-157-1-uterus_Gyne-uterus (153-162)_Rx_41F_HE_adenomatoid tumor
Gyne-157-2-uterus_Gyne-uterus (153-162)_Rx_46F_HE_adenomatoid tumor with cystic change
Gyne-157-3-uterus_Gyne-uterus (153-162)_Rx_79F_HE_adenomatoid tumor with mesothelial growth
Gyne-158-1-uterus_Gyne-uterus (153-162)_Rx_44F_HE_leiomyoma
Gyne-158-2-uterus_Gyne-uterus (153-162)_Rx_57F_HE_leiomyoma, multinodular (cotylidonoid leiomyoma-like)
Gyne-158-3-uterus_Gyne-uterus (153-162)_Rx_46F_HE_leiomyoma with cystic change
Gyne-158-4-uterus_Gyne-uterus (153-162)_Ex_50F_HE_leiomyoma with pseudoglandular structure
Gyne-158-5-uterus_Gyne-uterus (153-162)_Rx_40F_HE_leiomyoma with keloid-like stroma
Gyne-159-uterus_Gyne-uterus (153-162)_Rx_65F_HE_lipoleiomyoma
Gyne-160-1-uterus_Gyne-uterus (153-162)_Rx_31F_HE_vascular leiomyoma
Gyne-160-2-uterus_Gyne-uterus (153-162)_Rx_77F_HE_angiomyolipoma
Gyne-160-3-uterus_Gyne-uterus (153-162)_Rx_64F_HE_lipoma
Gyne-161-1-1-uterus_Gyne-uterus (153-162)_Rx_40F_HE_bizarre leiomyoma
Gyne-161-1-2-uterus_Gyne-uterus (153-162)_Rx_40'sF_HE/IHC_bizarre leiomyoma: PCNA vs. Ki-67
Gyne-161-2-uterus_Gyne-uterus (153-162)_Rx_42F_HE_cellular leiomyoma
Gyne-161-3-uterus_Gyne-uterus (153-162)_Rx_50F_HE_cellular leiomyoma with eosinophilic infiltration
Gyne-161-4-uterus_Gyne-uterus (153-162)_Rx_38F_HE_cellular leiomyoma with increased mitosis
Gyne-161-5-uterus_Gyne-uterus (153-162)_Rx_58F_HE_smooth muscle tumor of uncertain malignant potential (STUMP)
Gyne-161-6-uterus_Gyne-uterus (153-162)_Rx_48F_HE_intravenous leiomyomatosis of inferior vena cava
Gyne-161-7-uterus_Gyne-uterus (153-162)_Rx_30'sF_HE_benign metastasizing leiomyoma
Gyne-162-uterus_Gyne-uterus (153-162)_Rx_88F_HE_leiomyosarcoma
Gyne-163-1-oviduct_Gyne-oviduct (163-177)_Rx_49F_HE_Warthard cell nests
Gyne-163-2-oviduct_Gyne-oviduct (163-177)_Rx_46F_HE_theca cell nodule
Gyne-163-3-oviduct_Gyne-oviduct (163-177)_Rx_39F_HE_Wolffian duct rests
Gyne-163-4-oviduct_Gyne-oviduct (163-177)_Rx_56F_HE_ectopic adrenal cortex
Gyne-164-1-oviduct_Gyne-oviduct (163-177)_Rx_36F_HE_parovarian cyst torsion
Gyne-164-2-oviduct_Gyne-oviduct (163-177)_Rx_56F_HE_parovarian cyst with mucinous metaplasia
Gyne-164-3-oviduct_Gyne-oviduct (163-177)_Rx_41F_HE_parovarian cyst with adenofibromatous change
Gyne-165-1-oviduct_Gyne-oviduct (163-177)_Rx_34F_HE_tubal pregnancy, fetus (4 mm)
Gyne-165-2-oviduct_Gyne-oviduct (163-177)_Rx_37F_HE_tubal pregnancy, fetus (6 mm)
Gyne-165-3-oviduct_Gyne-oviduct (163-177)_Rx_34F_HE_tubal pregnancy (non-ruptured)
Gyne-166-1-oviduct_Gyne-oviduct (163-177)_Rx_53F_HE_E. coli-induced pyosalpinx-1
Gyne-166-2-oviduct_Gyne-oviduct (163-177)_Rx_53F_IHC (E. coli)_E. coli-induced pyosalpinx-2
Gyne-166-3-oviduct_Gyne-oviduct (163-177)_Rx_50F_HE_xanthogranulomatous salpingitis
Gyne-167-oviduct_Gyne-oviduct (163-177)_Rx_79F_HE_tubal tuberculosis
Gyne-168-1-oviduct_Gyne-oviduct (163-177)_Rx_25F_HE_chlamydial salpingitis-1
Gyne-168-2-oviduct_Gyne-oviduct (163-177)_Rx_25F_IHC (C. trachomatis)_chlamydial salpingitis-2
Gyne-169-1-oviduct_Gyne-oviduct (163-177)_Rx_46F_HE_hydrosalpinx
Gyne-169-2-oviduct_Gyne-oviduct (163-177)_Rx_18F_HE_hydrosalpinx with torsion and hemorrhagic necrosis
Gyne-169-3-oviduct_Gyne-oviduct (163-177)_Rx_30F_HE_hemorrhagic infarction of the oviduct
Gyne-170-oviduct_Gyne-oviduct (163-177)_Rx_50F_HE_focal dysplasia of fimbrial epithelial cells
Gyne-171-1-oviduct_Gyne-oviduct (163-177)_Rx_70F_HE_serous papillary adenocarcinoma of the oviduct
Gyne-171-2-oviduct_Gyne-oviduct (163-177)_Rx_53F_HE_serous papillary carcinoma of parovarian cyst
Gyne-172-1-1-oviduct_Gyne-oviduct (163-177)_Rx_69F_HE_serous papillary carcinoma, high-grade, with anaplastic transformation
Gyne-172-1-2-oviduct_Gyne-oviduct (163-177)_Rx_54F_HE/IHC/EM_poorly differentiated serous adenocarcinoma of the oviduct, expressing CD56 and p16
Gyne-172-2-1-oviduct_Gyne-oviduct (163-177)_Rx_69F_HE_carcinosarcoma (malignant mixed Müllerian tumor) of the oviduct-1
Gyne-172-2-2-oviduct_Gyne-oviduct (163-177)_Rx_69F_HE_carcinosarcoma (malignant mixed Müllerian tumor) of the oviduct-2
Gyne-173-1-oviduct_Gyne-oviduct (163-177)_Ex_24F_HE_female adnexal tumor of probable wolffian origin-1
Gyne-173-2-oviduct_Gyne-oviduct (163-177)_Ex_25F_HE_female adnexal tumor of probable wolffian origin-2
Gyne-174-oviduct_Gyne-oviduct (163-177)_Rx_50F_HE_adenomatoid tumor in parovarian cyst
Gyne-175-oviduct_Gyne-oviduct (163-177)_Rx_49F_HE_adenomyoma of the oviduct
Gyne-176-oviduct_Gyne-oviduct (163-177)_Rx_42F_HE_leiomyoma of the oviduct
Gyne-177-oviduct_Gyne-oviduct (163-177)_Rx_36F_HE_disseminated argentaffin carcinoid tumor (NET)
Gyne-178-ovary_Gyne-ovary (178-225)_Rx_45F_HE_ectopic adrenal cortical tissue
Gyne-179-1-ovary_Gyne-ovary (178-225)_Rx_36F_HE_normal mature follicles of the ovary with luteinization
Gyne-179-2-ovary_Gyne-ovary (178-225)_Ex_38F_HE_corpus luteum cyst
Gyne-179-3-ovary_Gyne-ovary (178-225)_Rx_39F_HE_hemorrhagic corpus luteum
Gyne-180-ovary_Gyne-ovary (178-225)_Rx_30'sF_HE_stromal hyperthecosis
Gyne-181-ovary_Gyne-ovary (178-225)_Rx_17F_HE_ovotestis (true hermaphroditism)
Gyne-182-ovary_Gyne-ovary (178-225)_Rx_20F_HE_polycystic ovary disease (Stein-Leventhal syndrome)
Gyne-183-ovary_Gyne-ovary (178-225)_Rx_34F_HE_ovarian pregnancy
Gyne-184-ovary_Gyne-ovary (178-225)_Rx_49F_HE_perioophoritis with fibrous adhesion
Gyne-185-ovary_Gyne-ovary (178-225)_Rx_35F_HE_ovarian actinomycosis
Gyne-186-ovary_Gyne-ovary (178-225)_Rx_31F_HE_ovarian schistosomiasis
Gyne-187-ovary_Gyne-ovary (178-225)_Rx_41F_HE_simple cyst
Gyne-188-1-ovary_Gyne-ovary (178-225)_Rx_30F_HE_endometrial cyst
Gyne-188-2-ovary_Gyne-ovary (178-225)_Rx_53F_HE_endometriosis with adenomatous hyperplasia
Gyne-189-1-ovary_Gyne-ovary (178-225)_Rx_69F_HE_fibroma with Meigs syndrome
Gyne-189-2-ovary_Gyne-ovary (178-225)_Rx_56F_HE_fibroma with myxoid stromal change
Gyne-190-1-ovary_Gyne-ovary (178-225)_Rx_52F_HE_thecofibroma
Gyne-190-2-ovary_Gyne-ovary (178-225)_Ex_51F_HE_luteinized thecoma with cystic change
Gyne-190-3-ovary_Gyne-ovary (178-225)_Rx_44F_HE_thecoma with sex cord elements
Gyne-190-4-ovary_Gyne-ovary (178-225)_Rx_70F_HE/pap_functioning thecoma in a 70-year-old female patient
Gyne-191-1-ovary_Gyne-ovary (178-225)_Rx_26F_HE_lipid cell tumor (steroid cell tumor)-1
Gyne-191-2-ovary_Gyne-ovary (178-225)_Rx_45F_HE/lipid/EM_lipid cell tumor (steroid cell tumor)-2
Gyne-192-1-ovary_Gyne-ovary (178-225)_Rx_65F_HE_granulosa cell tumor
Gyne-192-2-ovary_Gyne-ovary (178-225)_Rx_15F_HE_juvenile granulosa cell tumor
Gyne-193-1-ovary_Gyne-ovary (178-225)_Rx_49F_HE_Brenner's tumor with calcification
Gyne-193-2-ovary_Gyne-ovary (178-225)_Rx_76F_HE_Brenner's tumor with mucinous cystic change
Gyne-193-3-ovary_Gyne-ovary (178-225)_Rx_63F_HE_Brenner tumor, small-sized, incidental
Gyne-193-4-ovary_Gyne-ovary (178-225)_Rx_56F_HE_Brenner's tumor, proliferative, borderline
Gyne-194-ovary_Gyne-ovary (178-225)_Rx_22F_HE_sclerosing stromal tumor
Gyne-195-1-ovary_Gyne-ovary (178-225)_Rx_51F_HE_Sertoli cell tumor
Gyne-195-2-1-ovary_Gyne-ovary (178-225)_Rx_34F_HE_Sertoli-Leydig cell tumor-1
Gyne-195-2-2-ovary_Gyne-ovary (178-225)_Rx_76F_HE/EM_Sertoli-Leydig cell tumor-2
Gyne-195-3-ovary_Gyne-ovary (178-225)_Rx_20F_HE_Sertoli-Leydig cell tumor of intermediate differentiation with heterologous elements
Gyne-195-4-ovary_Gyne-ovary (178-225)_Rx_61F_HE_Sertoli-Leydig cell tumor, poorly differentiated (sarcomatoid type)
Gyne-196-1-ovary_Gyne-ovary (178-225)_Rx_13F_HE_sex cord tumor with annular tubules combined with juvenile granulosa cell tumor
Gyne-196-2-ovary_Gyne-ovary (178-225)_Rx_54F_HE_gynandroblastoma
Gyne-197-1-ovary_Gyne-ovary (178-225)_Rx_46F_HE_adenofibroma, serous borderline
Gyne-197-2-ovary_Gyne-ovary (178-225)_Rx_50F_HE_adenofibroma, endometrioid borderline
Gyne-197-3-ovary_Gyne-ovary (178-225)_Rx_74F_HE_adenofibroma, clear cell borderline
Gyne-198-1-ovary_Gyne-ovary (178-225)_Rx_79F_HE_serous papillary cystadenoma
Gyne-198-2-ovary_Gyne-ovary (178-225)_Rx_42F_HE_serous cystadenoma, oncocytic type
Gyne-199-1-ovary_Gyne-ovary (178-225)_Rx_61F_HE_serous papillary tumor, borderline
Gyne-199-2-ovary_Gyne-ovary (178-225)_Rx_52F_HE_serous cystadenoma focally with clear cell growth
Gyne-200-1-ovary_Gyne-ovary (178-225)_Rx_49F_HE_serous cystadenocarcinoma-1, pre-chemocherapy
Gyne-200-2-ovary_Gyne-ovary (178-225)_Rx_49F_HE_serous cystadenocarcinoma-2, post-chemotherapy
Gyne-201-ovary_Gyne-ovary (178-225)_Rx_70F_HE_serous papillary carcinoma, estrogen-producing
Gyne-202-1-ovary_Gyne-ovary (178-225)_Rx_35F_HE_serous cystadenocarcinoma, poorly differentiated
Gyne-202-2-ovary_Gyne-ovary (178-225)_Rx_61F_HE/IHC/EM_amylase-producing ovarian carcinoma
Gyne-203-1-ovary_Gyne-ovary (178-225)_Rx_40F_HE_serous cystadenocarcinoma with normal-sized ovary cancer syndrome
Gyne-203-2-ovary_Gyne-ovary (178-225)_Rx_71F_HE_surface papillary serous adenocarcinoma
Gyne-203-3-ovary_Gyne-ovary (178-225)_Rx_25F/25F/48F_HE/IHC/macro_gross appearance of ovarian surface papillary serous tumors
Gyne-204-ovary_Gyne-ovary (178-225)_Rx_42F_HE_Müllerian mixed epithelial-papillary cystadenoma of borderline malignancy
Gyne-205-1-1-ovary_Gyne-ovary (178-225)_Rx_40'sF_HE_mucinous cystadenoma, Müllerian type, with Brenner's tumor-1
Gyne-205-1-2-ovary_Gyne-ovary (178-225)_Rx_40'sF_AB-PAS_mucinous cystadenoma, Müllerian type, with Brenner's tumor-2
Gyne-205-2-1-ovary_Gyne-ovary (178-225)_Rx_78F_HE_mucinous cystadenoma, gastric type-1
Gyne-205-2-2-ovary_Gyne-ovary (178-225)_Rx_78F_IHC (MUC5AC)_mucinous cystadenoma, gastric type-2
Gyne-205-2-3-ovary_Gyne-ovary (178-225)_Rx_78F_IHC (CGA)_mucinous cystadenoma, gastric type-3
Gyne-205-3-ovary_Gyne-ovary (178-225)_Rx_75F_HE_mucinous cystadenoma, enteric type
Gyne-205-4-ovary_Gyne-ovary (178-225)_Rx_31F_HE_mucinous cystadenoma in pregnancy
Gyne-205-5-ovary_Gyne-ovary (178-225)_Rx_32F_HE_mucinous cystadenoma with eosinophlic mucin
Gyne-205-6-ovary_Gyne-ovary (178-225)_Rx_63F_HE/macro_Budd-Chiari syndrome caused by mucinous cystadenoma of the ovary
Gyne-206-1-ovary_Gyne-ovary (178-225)_Rx_45F_HE_mucinous cystic tumor, borderline
Gyne-206-2-ovary_Gyne-ovary (178-225)_Rx_53F_HE_mucinous cystic tumor, borderline, with endometrial stroma
Gyne-207-1-ovary_Gyne-ovary (178-225)_Rx_49F_HE_mucinous cystadenocarcinoma in mucinous cystadenoma
Gyne-207-2-ovary_Gyne-ovary (178-225)_Rx_46F_HE_mucinous cystadenocarcinoma, enteric type
Gyne-207-3-ovary_Gyne-ovary (178-225)_Rx_43F_HE_AFP-producing enteric-type cystadenocarcinoma
Gyne-207-4-ovary_Gyne-ovary (178-225)_Rx_adultsF_HE/PAS/IHC/macro_gross appearance of mucinous cystic tumors
Gyne-208-ovary_Gyne-ovary (178-225)_Rx_67F_HE_pseudomyxoma peritonei (recurrence of mucinous cystadenocarcinoma) -2
Gyne-209-ovary_Gyne-ovary (178-225)_Rx_50F_HE_cystic endometrioid tumor, borderline malignancy
Gyne-210-1-ovary_Gyne-ovary (178-225)_Rx_49F_HE_endometrioid carcinoma with squamous differentiation (adenoacanthoma)
Gyne-210-2-1-ovary_Gyne-ovary (178-225)_Rx_69F_HE_endometrioid carcinoma, secretory variant-1
Gyne-210-2-2-ovary_Gyne-ovary (178-225)_Rx_69F_HE/PAS/lipid/IHC/EM/MRI/macro_endometrioid carcinoma, secretory variant-2
Gyne-210-3-ovary_Gyne-ovary (178-225)_Rx_67F_HE_endometrioid carcinoma, poorly differentiated (G3)
Gyne-211-1-ovary_Gyne-ovary (178-225)_Rx_61F_HE_clear cell carcinoma arising from clear cell adenofibroma
Gyne-211-2-ovary_Gyne-ovary (178-225)_Rx_76F_HE_clear cell carcinoma, intracystic non-invasive
Gyne-211-3-ovary_Gyne-ovary (178-225)_Rx_50F_HE_clear cell carcinoma arising in endometrial cyst
Gyne-212-1-ovary_Gyne-ovary (178-225)_Rx_48F_HE_clear cell carcinoma of the ovary-1
Gyne-212-2-ovary_Gyne-ovary (178-225)_Rx/cytology_48F_HE/IHC/EM_clear cell carcinoma of the ovary-2
Gyne-213-1-ovary_Gyne-ovary (178-225)_Rx_53F_HE_epidermal cyst
Gyne-213-2-ovary_Gyne-ovary (178-225)_Rx_48F_HE_dermoid cyst with lipogranulomatous reactions
Gyne-213-3-ovary_Gyne-ovary (178-225)_Rx_30F_HE_mature cystic teratoma-1
Gyne-213-4-ovary_Gyne-ovary (178-225)_Rx_26F_HE_mature cystic teratoma-2
Gyne-213-5-ovary_Gyne-ovary (178-225)_Rx_35F_HE_prostatic tissue in mature ovarian teratoma-1
Gyne-213-6-ovary_Gyne-ovary (178-225)_Rx_80F_HE/IHC/macro_prostatic tissue in mature ovarian teratoma-2
Gyne-214-1-ovary_Gyne-ovary (178-225)_Rx_44F_HE_struma ovarii
Gyne-214-2-ovary_Gyne-ovary (178-225)_Rx_33F_HE_ovarian strumal carcinoid
Gyne-215-1-ovary_Gyne-ovary (178-225)_Rx_8F_HE_immature teratoma/recurrence and peritoneal dissemination
Gyne-215-2-ovary_Gyne-ovary (178-225)_Rx_30F_HE/IHC/macro_immature teratoma of the ovary with AFP production
Gyne-216-1-ovary_Gyne-ovary (178-225)_Rx_26F_HE (ovary)_ovarian teratoma with gliomatosis peritonei-1
Gyne-216-2-ovary_Gyne-ovary (178-225)_Ex_26F_HE (peritoneum)_ovarian teratoma with gliomatosis peritonei-2
Gyne-217-1-ovary_Gyne-ovary (178-225)_Rx_38F_HE_urothelial carcinoma arising in benign cystic teratoma
Gyne-217-2-1-ovary_Gyne-ovary (178-225)_Rx_58F_HE_malignant melanoma arising in dermoid cyst-1
Gyne-217-2-2-ovary_Gyne-ovary (178-225)_Rx_58F_HE/Pap/Giemsa/macro_malignant melanoma arising in dermoid cyst-2
Gyne-217-3-ovary_Gyne-ovary (178-225)_Rx_33F_HE_inflammatory myofibroblastic tumor in ovarian teratoma
Gyne-218-ovary_Gyne-ovary (178-225)_Rx_31F_HE_dysgerminoma
Gyne-219-1-ovary_Gyne-ovary (178-225)_Rx_21F_HE_yolk sac tumor-1
Gyne-219-2-ovary_Gyne-ovary (178-225)_Rx_19F_HE/IHC/EM_yolk sac tumor of the ovary-2
Gyne-220-ovary_Gyne-ovary (178-225)_Rx_57F_HE_malignant mixed Müllerian tumor (carcinosarcoma)
Gyne-221-ovary_Gyne-ovary (178-225)_Rx_66F_HE_squamous cell carcinoma with adenofibroma-like clear cell carcinoma, high-grade
Gyne-222-ovary_Gyne-ovary (178-225)_Rx_70F_HE_anaplastic carcinoma of the ovary
Gyne-223-ovary_Gyne-ovary (178-225)_Rx_38F_HE_Krukenberg tumor (metastatic signet ring cell carcinoma of the stomach)
Gyne-224-ovary_Gyne-ovary (178-225)_Rx_43F_HE_metastatic mucinous carcinoma of the colon
Gyne-224-a-ovary_Gyne-ovary (178-225)_Au_40'sF_HE/Giemsa/macro_ovarian invasion of acute myeloblastic leukemia
Gyne-225-ovary_Gyne-ovary (178-225)_Rx_23F_HE_Burkitt lymphoma
Gyne-226-cord_Gyne-cord (226-231)_Delivery_37F_HE_allantoic duct remnant
Gyne-226-a-cord_Gyne-cord (226-231)_Delivery_23fwF_macro_umbilical cord hypercoiling
Gyne-227-cord_Gyne-cord (226-231)_Delivery_39fwF_HE_single umbilical artery
Gyne-228-cord_Gyne-cord (226-231)_Delivery_31F_HE_thrombosis of the umbilical artery
Gyne-229-cord_Gyne-cord (226-231)_Delivery_22F_HE_endarteritis of umbilical arteries
Gyne-230-1-cord_Gyne-cord (226-231)_Delivery_33fw_HE_syphilitic funisitis-1
Gyne-230-2-cord_Gyne-cord (226-231)_Delivery_33fw_IHC (T. pallidum)_syphilitic funisitis-2
Gyne-231-cord_Gyne-cord (226-231)_Delivery_30'sF_HE_subacute necrotizing funiculitis
Gyne-232-placenta_Gyne-placenta (232-253)_Delivery_21F_HE_the 20th week placenta
Gyne-232-a-placenta_Gyne-placenta (232-253)_Abortion/delivery_adults_HE/TUNEL_apoptotic cells in placental villi
Gyne-233-placenta_Gyne-placenta (232-253)_Delivery_28F_HE_amnion nodosum-like change
Gyne-234-placenta_Gyne-placenta (232-253)_Delivery_40F_HE_intervillous thrombosis
Gyne-235-1-placenta_Gyne-placenta (232-253)_Delivery_26F_HE_monozygotic twin placenta
Gyne-235-2-placenta_Gyne-placenta (232-253)_Delivery_30F_VB-HE_fetus papyraceus
Gyne-236-placenta_Gyne-placenta (232-253)_Delivery_36F_HE/EM_galactosialidosis and I-cell disease, placental pathology
Gyne-237-1-placenta_Gyne-placenta (232-253)_Delivery_37F_HE_abruptio placentae-1
Gyne-237-2-placenta_Gyne-placenta (232-253)_Delivery_37F_IHC (TIA-1)_abruptio placentae-2
Gyne-238-placenta_Gyne-placenta (232-253)_Delivery_38F_HE_placenta accreta
Gyne-239-placenta_Gyne-placenta (232-253)_Delivery_30F_HE_hypertensive disorder of pregnancy (preeclampsia)
Gyne-240-1-placenta_Gyne-placenta (232-253)_Delivery_27F_HE_placental dysfunction with diffuse decidual necrosis
Gyne-240-2-placenta_Gyne-placenta (232-253)_Delivery_25F_HE_stillbirth caused by decidual dysfunction
Gyne-240-3-placenta_Gyne-placenta (232-253)_Delivery_28F_HE_parietal deciduitis
Gyne-241-1-placenta_Gyne-placenta (232-253)_D&C_30'sF_HE_streptococcal infection in the placental rest after delivery-1
Gyne-241-2-placenta_Gyne-placenta (232-253)_D&C_30'sF_IHC(Streptococus)_streptococcal infection in the placental rest after delivery-1
Gyne-242-1-placenta_Gyne-placenta (232-253)_Au_25F_HE_fulminant pneumococcal infection caused by placental infection-1
Gyne-242-2-placenta_Gyne-placenta (232-253)_Au_25F_HE/IHC_fulminant pneumococcal infection caused by placental infection-2
Gyne-243-placenta_Gyne-placenta (232-253)_Delivery_32F_HE_listeriosis
Gyne-244-1-placenta_Gyne-placenta (232-253)_Delivery_30'sF_HE_syphilitic placentitis-1
Gyne-244-2-placenta_Gyne-placenta (232-253)_Delivery_30'sF_IHC (TP Ag)_syphilitic placentitis-2
Gyne-245-1-placenta_Gyne-placenta (232-253)_Delivery_adult F_HE_CMV placentitis-1
Gyne-245-2-placenta_Gyne-placenta (232-253)_Delivery_adult F_IHC (Leu M1=CD15)_CMV placentitis-2
Gyne-246-1-placenta_Gyne-placenta (232-253)_Au_25fwM_HE_hydrops fetalis provoked after erythema infectiosum at the 10th gestational week-1
Gyne-246-2-placenta_Gyne-placenta (232-253)_Au_25fwM_IHC (Parvo B19)_hydrops fetalis provoked after erythema infectiosum at the 10th gestational week-2
Gyne-246-3-placenta_Gyne-placenta (232-253)_Au_25fwM_HE/IHC/macro_hydrops fetalis due to Parvovirus B19 infection: an autopsy case
Gyne-247-placenta_Gyne-placenta (232-253)_D&C_adult F_HE_rubella placentitis
Gyne-248-placenta_Gyne-placenta (232-253)_Delivery_30'sF_HE_measles placentitis
Gyne-249-placenta_Gyne-placenta (232-253)_D&C_30'sF_HE_toxoplasmosis
Gyne-250-placenta_Gyne-placenta (232-253)_Delivery_40F_HE_chorioamnionitis with endangiitis
Gyne-251-1-placenta_Gyne-placenta (232-253)_D&C_27F_HE_chorioamnionitis-1
Gyne-251-2-placenta_Gyne-placenta (232-253)_D&C_27F_IHC (B. cereus)_chorioamnionitis-2
Gyne-251-a-placenta_Gyne-placenta (232-253)_D&C_37F_HE_chorioamnionitis with placental abscess formation
Gyne-252-placenta_Gyne-placenta (232-253)_Delivery_26F_HE_capillary hemangioma of placenta (chorangioma)
Gyne-253-1-placenta_Gyne-placenta (232-253)_Delivery_29F_HE_cellular hemangioma-1
Gyne-253-2-placenta_Gyne-placenta (232-253)_Delivery_29F_silver_cellular hemangioma-2